CINCINNATI--(BUSINESS WIRE)--Aug 13, 2019--
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following investor conference in September:
Baird Global Healthcare Conference
Location: New York, NY
Date: Wednesday, September 4, 2019
Presentation: 9:05 a.m. ET
Speakers: Dr. August Troendle, President & Chief Executive Officer, and Jesse Geiger, Chief Financial Officer & Chief Operating Officer, Laboratory Operations
A live webcast of each presentation will be accessible through the “Investors” section of the Company’s website at www.medpace.com and will be available for replay following each event.
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 3,200 people across 37 countries.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190813005556/en/
CONTACT: Media Contact:
Medpace Holdings, Inc.
KEYWORD: NEW YORK OHIO UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: SURGERY PHARMACEUTICAL ONCOLOGY MEDICAL DEVICES INFECTIOUS DISEASES HOSPITALS FINANCE CLINICAL TRIALS SCIENCE CARDIOLOGY BIOTECHNOLOGY PROFESSIONAL SERVICES HEALTH FDA RESEARCH GENERAL HEALTH
SOURCE: Medpace Holdings, Inc.
Copyright Business Wire 2019.
PUB: 08/13/2019 04:05 PM/DISC: 08/13/2019 04:05 PM